Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial by Broekhuijsen, Kim, MD, van Baaren, Gert-Jan, MD, van Pampus, Maria G, MD, Ganzevoort, Wessel, MD, Sikkema, J Marko, MD, Woiski, Mallory D, MD, Oudijk, Martijn A, MD, Bloemenkamp, Kitty W M, MD, Scheepers, Hubertina C J, MD, Bremer, Henk A, MD, Rijnders, Robbert J P, MD, van Loon, Aren J, MD, Perquin, Denise A M, MD, Sporken, Jan M J, MD, Papatsonis, Dimitri N M, MD, van Huizen, Marloes E, MD, Vredevoogd, Corla B, MD, Brons, Jozien T J, MD, Kaplan, Mesrure, MD, van Kaam, Anton H, Prof, Groen, Henk, MD, Porath, Martina M, MD, van den Berg, Paul P, Prof, Mol, Ben W J, Prof, Franssen, Maureen T M, MD, Langenveld, Josje, MD

Get full text

Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): an open-label, randomised controlled trial by Jozwiak, Marta, MD, Rengerink, Katrien Oude, MSc, Benthem, Marjan, MSc, van Beek, Erik, MD, Dijksterhuis, Marja GK, MD, de Graaf, Irene M, MD, van Huizen, Marloes E, MD, Oudijk, Martijn A, MD, Papatsonis, Dimitri NM, MD, Perquin, Denise AM, MD, Porath, Martina, MD, van der Post, Joris AM, Prof, Rijnders, Robbert JP, MD, Scheepers, Hubertina CJ, MD, Spaanderman, Marc EA, Prof, van Pampus, Maria G, MD, de Leeuw, Jan Willem, MD, Mol, Ben WJ, Prof, Bloemenkamp, Kitty WM, Dr

Get full text